交易 Monopar Therapeutics Inc. - MNPR CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | - | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.024874% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.002651% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|
Monopar Therapeutics Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Monday, April 3, 2023 | ||
时间(协调世界时) (UTC) 17:00 | 国家 US
| 事件 Monopar Therapeutics Inc at Jefferies Radiopharma Innovation Summit Monopar Therapeutics Inc at Jefferies Radiopharma Innovation SummitForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | |||
總營業費用 | 10.5369 | 9.12725 | 6.50888 | 4.32376 | 3.33115 |
銷售/一般/行政費用,總計 | 2.94528 | 2.63404 | 2.44368 | 2.35524 | 1.55669 |
研究與開發 | 7.5916 | 6.49321 | 4.0652 | 1.96852 | 1.77445 |
營業收入 | -10.5369 | -9.12725 | -6.50888 | -4.32376 | -3.33115 |
利息收入(費用),非經營淨值 | 0.02124 | 0.02402 | 0.0819 | 0.09889 | 0.10322 |
稅前淨收入 | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
稅後淨收入 | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
未計算非常項目前的淨收益 | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
淨收入 | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
普通股股東可獲收益 (不含非經常性項目) | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
普通股股東可獲收益 (含非經常性項目) | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
攤薄淨收入 | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
攤薄後加權平均股 | 12.7182 | 12.4722 | 10.9583 | 10.421 | 10.421 |
扣除特別項目的每股攤薄盈利 | -0.82682 | -0.72988 | -0.57533 | -0.40542 | -0.30975 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -0.82682 | -0.72988 | -0.57533 | -0.40542 | -0.30975 |
其他,淨值 | 0 | 0.1224 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 2.909 | 2.40735 | 2.76335 | 2.45719 | 2.68112 |
銷售/一般/行政費用,總計 | 0.80874 | 0.67512 | 0.68488 | 0.77925 | 0.69844 |
研究與開發 | 2.10297 | 1.73223 | 2.07847 | 1.67793 | 1.98268 |
營業收入 | -2.909 | -2.40735 | -2.76335 | -2.45719 | -2.68112 |
利息收入(費用),非經營淨值 | 0.01266 | 0.0077 | 0.00042 | 0.00046 | 0.00053 |
稅前淨收入 | -2.89634 | -2.39965 | -2.76293 | -2.45672 | -2.68059 |
稅後淨收入 | -2.89634 | -2.39965 | -2.76293 | -2.45672 | -2.68059 |
未計算非常項目前的淨收益 | -2.89634 | -2.39965 | -2.76293 | -2.45672 | -2.68059 |
淨收入 | -2.89634 | -2.39965 | -2.76293 | -2.45672 | -2.68059 |
普通股股東可獲收益 (不含非經常性項目) | -2.89634 | -2.39965 | -2.76293 | -2.45672 | -2.68059 |
普通股股東可獲收益 (含非經常性項目) | -2.89634 | -2.39965 | -2.76293 | -2.45672 | -2.68059 |
攤薄淨收入 | -2.89634 | -2.39965 | -2.76293 | -2.45672 | -2.68059 |
攤薄後加權平均股 | 12.8795 | 12.7547 | 12.6324 | 12.6044 | 12.5919 |
扣除特別項目的每股攤薄盈利 | -0.22488 | -0.18814 | -0.21872 | -0.19491 | -0.21288 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
每股正常攤薄盈利 | -0.22488 | -0.18814 | -0.21872 | -0.19491 | -0.21288 |
Other Operating Expenses, Total | -0.00271 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流動資産總額 | 20.5216 | 16.7998 | 13.2296 | 7.25222 | 9.13124 |
現金和短期投資 | 20.3039 | 16.7371 | 13.2139 | 6.89277 | 8.98189 |
現金等價物 | 20.3039 | 16.7371 | 13.2139 | 6.89277 | 8.98189 |
Other Current Assets, Total | 0.21775 | 0.06269 | 0.01571 | 0.35945 | 0.14934 |
Total Assets | 20.5216 | 16.8687 | 13.352 | 7.31796 | 9.93127 |
Other Long Term Assets, Total | 0 | 0.06886 | 0.12238 | 0.06573 | 0.80003 |
Total Current Liabilities | 1.58054 | 1.17667 | 0.72417 | 0.39955 | 0.31187 |
Payable/Accrued | 1.58054 | 1.17667 | 0.72417 | 0.39955 | 0.31187 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1.58054 | 1.17667 | 0.72417 | 0.39955 | 0.31187 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 18.9411 | 15.692 | 12.6279 | 6.9184 | 9.6194 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.0126 | 0.01145 | 0.01059 | 0.00929 | 0.00929 |
Additional Paid-In Capital | 60.22 | 47.8736 | 38.5088 | 28.5672 | 28.0379 |
Other Equity, Total | -0.00316 | -0.00787 | -0.01097 | -0.0024 | -18.4278 |
Total Liabilities & Shareholders’ Equity | 20.5216 | 16.8687 | 13.352 | 7.31796 | 9.93127 |
Total Common Shares Outstanding | 12.5981 | 11.4535 | 10.6215 | 10.421 | 10.421 |
Retained Earnings (Accumulated Deficit) | -41.2884 | -32.1852 | -25.8806 | -21.6557 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 18.0127 | 20.5216 | 22.4484 | 24.3884 | 25.8377 |
現金和短期投資 | 17.819 | 20.3039 | 22.3416 | 24.2929 | 25.7231 |
現金等價物 | 17.819 | 20.3039 | 22.3416 | 24.2929 | 25.7231 |
Other Current Assets, Total | 0.19364 | 0.21775 | 0.1068 | 0.09556 | 0.11457 |
Total Assets | 18.0664 | 20.5216 | 22.5172 | 24.4573 | 25.9065 |
Other Long Term Assets, Total | 0 | 0.06886 | 0.06886 | 0.06886 | |
Total Current Liabilities | 1.07412 | 1.58054 | 1.23994 | 1.10364 | 0.80627 |
Payable/Accrued | 1.04815 | 1.58054 | 1.23994 | 1.10364 | 0.80627 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1.09946 | 1.58054 | 1.23994 | 1.10364 | 0.80627 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 16.9669 | 18.9411 | 21.2773 | 23.3536 | 25.1003 |
Common Stock | 0.01262 | 0.0126 | 0.01259 | 0.01258 | 0.01257 |
Additional Paid-In Capital | 60.7031 | 60.22 | 59.8776 | 59.4955 | 59.162 |
Retained Earnings (Accumulated Deficit) | -43.7451 | -41.2884 | -38.6078 | -36.1493 | -34.0692 |
Other Equity, Total | -0.00374 | -0.00316 | -0.00515 | -0.00516 | -0.0051 |
Total Liabilities & Shareholders’ Equity | 18.0664 | 20.5216 | 22.5172 | 24.4573 | 25.9065 |
Total Common Shares Outstanding | 12.6206 | 12.5981 | 12.5906 | 12.5827 | 12.5699 |
Property/Plant/Equipment, Total - Net | 0.05369 | ||||
Accrued Expenses | 0.02598 | ||||
Other Liabilities, Total | 0.02534 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -10.5156 | -9.10322 | -6.30457 | -4.22487 | -3.22793 |
經營活動産生的現金 | -7.22856 | -7.3174 | -4.66227 | -3.01768 | -2.68049 |
非現金物品 | 1.64126 | 1.46805 | 1.19849 | 1.01117 | 0.52933 |
營運資金的變化 | 1.64582 | 0.31777 | 0.44381 | 0.19602 | 0.01811 |
融資活動産生的現金 | 0.03287 | 10.8795 | 8.18212 | 9.34741 | -0.20627 |
融資現金流項目 | -0.07663 | -0.06325 | -0.11557 | -0.98481 | -0.20627 |
股票的發行(報廢),淨額 | 0.10951 | 10.9428 | 8.17529 | 10.3322 | 0 |
現金淨變化 | -12.1177 | 3.56676 | 3.52318 | 6.32116 | -2.88915 |
外彙效應 | -0.00348 | 0.00462 | 0.00333 | -0.00857 | -0.0024 |
Cash Taxes Paid | 0 | -0.0111 | |||
債務的發行(退還),淨額 | 0.1224 | ||||
投資活動産生的現金 | -4.91851 | ||||
其他投資現金流量項目,總計 | -4.91851 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -10.5156 | -7.6193 | -5.21965 | -2.45672 | -9.10322 |
Cash From Operating Activities | -7.22856 | -5.92675 | -3.77828 | -2.4675 | -7.3174 |
Non-Cash Items | 1.64126 | 1.24785 | 0.85711 | 0.49981 | 1.46805 |
Changes in Working Capital | 1.64582 | 0.4447 | 0.58427 | -0.51059 | 0.31777 |
Cash From Financing Activities | 0.03287 | -0.10586 | -0.08213 | -0.01667 | 10.8795 |
Financing Cash Flow Items | -0.07663 | -0.10603 | -0.08217 | -0.01667 | -0.06325 |
Issuance (Retirement) of Stock, Net | 0.10951 | 0.00017 | 0.00004 | 0 | 10.9428 |
Foreign Exchange Effects | -0.00348 | 0.04521 | 0.0201 | -0.00066 | 0.00462 |
Net Change in Cash | -12.1177 | -5.98741 | -3.8403 | -2.48483 | 3.56676 |
Issuance (Retirement) of Debt, Net | |||||
Cash From Investing Activities | -4.91851 | ||||
Other Investing Cash Flow Items, Total | -4.91851 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Tacticgem LLC | Corporation | 31.1621 | 4111273 | 0 | 2022-04-15 | LOW |
Gem Pharmaceuticals LLC | Corporation | 23.1589 | 3055394 | 0 | 2022-04-15 | LOW |
Hendricks (Diane) | Individual Investor | 3.553 | 468750 | 0 | 2022-04-15 | LOW |
Brown Michael J | Individual Investor | 1.711 | 225730 | 2859 | 2022-12-31 | LOW |
Tactic Pharma LLC | Corporation | 1.2633 | 166667 | 0 | 2022-04-15 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.7578 | 99976 | 97 | 2022-12-31 | LOW |
Robinson (Chandler D) | Individual Investor | 0.5816 | 76730 | 4396 | 2023-01-01 | LOW |
Starr (Christopher M) | Individual Investor | 0.4937 | 65130 | 2859 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3175 | 41892 | 2721 | 2022-12-31 | LOW |
Cittadine (Andrew) | Individual Investor | 0.2038 | 26894 | 2656 | 2022-12-31 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1735 | 22884 | -293 | 2022-12-31 | LOW |
Mazar (Andrew Paul) | Individual Investor | 0.1677 | 22125 | 0 | 2022-04-15 | LOW |
Klausner (Arthur J) | Individual Investor | 0.1571 | 20730 | 2859 | 2022-12-31 | LOW |
Tsuchimoto (Kim R) | Individual Investor | 0.1403 | 18507 | 728 | 2023-01-01 | MED |
Anderson (Raymond William) | Individual Investor | 0.1268 | 16730 | 2859 | 2022-12-31 | MED |
Northern Trust Global Investments | Investment Advisor | 0.1 | 13197 | 0 | 2022-12-31 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.0303 | 4000 | 0 | 2022-12-31 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.0239 | 3154 | -2245 | 2022-12-31 | LOW |
Tower Research Capital LLC | Hedge Fund | 0.0215 | 2831 | -300 | 2022-12-31 | HIGH |
Paragon Wealth Strategies, LLC | Investment Advisor | 0.0004 | 58 | 0 | 2022-12-31 | HIGH |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Biotechnology & Medical Research (NEC) |
1000 Skokie Blvd Ste 350
WILMETTE
ILLINOIS 60091-1146
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 500.000 多名交易者,選擇與 Capital.com 交易